SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) — Samumed announced today top-line data from its phase 2b trial of SM04690 in knee osteoarthritis (OA). Results showed that treatment with a single intra-articular injection of SM04690 demonstrated significant improvements in pain, function and patient global scores in two separate doses. Further details can be found here. Samumed’s […]